A carregar...

Adjuvant chemotherapy for luminal A breast cancer: a prospective study comparing two popular chemotherapy regimens

INTRODUCTION: Based on the variable benefit of taxanes in the adjuvant setting of early breast cancer in certain tumor phenotypes, especially in human epidermal growth factor receptor (HER)2-positive and triple-negative disease, and with the observation of a lesser benefit in luminal A, this researc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kader, Yasser Abdel, El-Nahas, Tamer, Sakr, Amr
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3745289/
https://ncbi.nlm.nih.gov/pubmed/23966793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S48397
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!